Johnson & Johnson Patient Assistance Program: Pulmonary Hypertension

Funded

About

The Johnson & Johnson Patient Assistance Program: Pulmonary Hypertension offers vital support for patients requiring Opsumit, Tracleer, Veletri, Uptravi, and Opsynvi. By providing potentially no-cost access to these medications for eligible underinsured patients, the Johnson & Johnson Patient Assistance Program aims to alleviate the financial burden of drug therapy for pulmonary hypertension patients. Emphasizing on insured patients living in the United States and meeting specific income criteria, this program remains a crucial resource for those in need of cost-effective healthcare solutions.

Insurance requirements: Commercially insured, Medicare / Medicaid, Underinsured

Enrollment Forms

Enrollment Form

Program Requirements

•Valid only for residents in the US and Puerto Rico

•Enrollment Required: Yes

•Coverage Required: No

•Needs Based: Yes

•Activation Required: No

Program Details

•Eligible underinsured patients may be able to receive medication at no cost for up to one year

•Program provides medication cost assistance only; does not cover the costs to receive treatment

•Patients with Medicare Part D may be asked to submit a report from their pharmacy or an EOB statement from their insurance that shows their outofpocket costs for the current year

•HCP should fax the completed enrollment form and supporting documents to: 8662790669

•For assistance or additional information, call 8337420791, Monday through Friday, 8:00 am to 8:00 pm ET

Enrollment Forms

Enrollment Form